China Single Cell Analysis Market Size & Outlook
China single cell analysis market, 2018-2030 (US$M)
Related Markets
China single cell analysis market highlights
- The China single cell analysis market generated a revenue of USD 139.7 million in 2022 and is expected to reach USD 540.0 million by 2030.
- The China market is expected to grow at a CAGR of 18.4% from 2023 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2022.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Single cell analysis market data book summary
| Market revenue in 2022 | USD 139.7 million |
| Market revenue in 2030 | USD 540.0 million |
| Growth rate | 18.4% (CAGR from 2022 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Bio-Rad Laboratories Inc, Illumina Inc, Merck KGaA, Becton Dickinson & Co, Standard BioTools Inc, 10x Genomics Inc Ordinary Shares - Class A, BGI Group, Novogene |
Other key industry trends
- In terms of revenue, China accounted for 3.6% of the global single cell analysis market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China single cell analysis market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 437.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Single Cell Analysis Market Scope
Single Cell Analysis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China single cell analysis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to single cell analysis market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 54.83% in 2022. Horizon Databook has segmented the China single cell analysis market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
According to Novo tech in September 2023, China emerged as a hub for cell and gene therapy, securing the second position globally in patent applications and registered clinical trials, following the U.S. As per China CDC Weekly, in 2022, there was an increase of 15.85%, 68.62%, and −18.04% in cancer incidence, prevalence, and mortality compared to 244.75, 973.80, and 140.66 per 100,000 total population, respectively, in 2019.
Thus, market players are focusing on cancer immunotherapy-based products in China. Some of the major companies in the market are Innovative Cellular Therapeutics, Cellular Biomedicine Group, CARs gen Therapeutics, Person Gen Biomedicine, and Hebei Senlang Biotechnology.
Reasons to subscribe to China single cell analysis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China single cell analysis market databook
-
Our clientele includes a mix of single cell analysis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China single cell analysis market , including forecasts for subscribers. This country databook contains high-level insights into China single cell analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China single cell analysis market size, by product, 2018-2030 (US$M)
China Single Cell Analysis Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
